CRKL is a central tyrosine phosphorylated protein detected in cells of patients with CML, suggesting that its association with BCR-ABL1 plays an important role in the pathogenesis of the disease. This evidence concerns the gene CRKL and chronic myelogenous leukemia, BCR-ABL1 positive.